Sphereon and Triall receive an R&D grant from the Dutch Government
We’re very pleased to announce that Sphereon.com and Triall.io are rewarded an important R&D grant from the Dutch Government to research and build a patient-oriented eConsent solution, together with a secure personal data vault (a.k.a. Credential Wallet).
The proposed project scored very high on criteria such as:
- Technological innovation
- Economic value
- Quality of the collaboration
- Social impact
Sphereon and Triall will be the first in the world to leverage the privacy-preserving technologies of Self-Sovereign Identity (SSI) and Verifiable Credentials (W3C-VC) in actually digitizing the Informed Consent process in healthcare and clinical research.
Verifiable Guardianship in Clinical Trials
Informed Consent is essential for patient safety, ethical research conduct, and regulatory compliance. Unfortunately, the Informed Consent process is often a source of audit and inspection problems, resulting from issues related to record keeping, protocol amendments, and signatures.
The project will focus on researching and applying new technologies to solve these problems, as well as solving the complex challenges surrounding guardianship of incapacitated persons, like elderly people suffering from dementia, people with mental disabilities or a serious psychological illness, patients in a coma, or are legally unauthorized, like minors.
The ultimate deliverable of this project is a state-of-the-art eConsent application for investigators, patients, and their guardians. Moreover, the SSI technologies to be developed in this project form a logical stepping stone in Triall’s development roadmap, creating the building blocks for other tools, applications, and integrations within the Triall and other SSI ecosystems.
Cooperation is key
As we say so often, cooperation is key.
We are convinced that without the knowledge and experience of our other partner Triall in Clinical Trial Research, we would not be as successful as we are now.
Triall brings Web 3 technologies to medical research. They are creating a digital ecosystem of blockchain-integrated software solutions to secure and streamline the development of new medicines during clinical trials.
Leveraging blockchain infrastructure makes clinical trial data tamper-resistant. It also enables secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes.